Science Explorer Back to mapMap
Discussion
Institution · Association for Frontotemporal Degeneration

Most cited papers from Association for Frontotemporal Degeneration

Association for Frontotemporal Degeneration

What are the most cited papers from Association for Frontotemporal Degeneration?

The most cited paper from Association for Frontotemporal Degeneration is "Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria" (Günter U. Höglinger et al., 2017), with 2,430 citations. Next come "Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium" (170) and "Which ante mortem clinical features predict progressive supranuclear palsy pathology?" (169).

Showing 50 of 64 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria Günter U. Höglinger et al. · Movement Disorders Open access 3 May 2017 2,430
2 Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium Toji Miyagawa et al. · Alzheimer s & Dementia Open access 2020 170
3 Which ante mortem clinical features predict progressive supranuclear palsy pathology? Gesine Respondek et al. · Movement Disorders Open access 13 May 2017 169
4 How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy Max‐Joseph Grimm et al. · Movement Disorders Open access 18 Mar 2019 144
5 Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases David G. Coughlin, Howard I. Hurtig, David John Irwin · Movement Disorders Open access 29 Oct 2019 138
6 The social and economic burden of frontotemporal degeneration James E. Galvin, David H. Howard, Sharon S. Denny et al. · Neurology Open access 5 Oct 2017 116
7 Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy David A. Wolk et al. · Alzheimer s & Dementia Open access 2025 89
8 Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases Eliana Marisa Ramos et al. · Alzheimer s & Dementia Open access 2020 83
9 Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development Adam L. Boxer et al. · Alzheimer s & Dementia Open access 5 Oct 2012 82
10 Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies Gesine Respondek, Max‐Joseph Grimm, Ines Piot et al. · Movement Disorders Open access 30 Sep 2019 76
11 New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures Adam L. Boxer et al. · Alzheimer s & Dementia Open access 23 Oct 2019 70
12 The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology Bradley F. Boeve et al. · Alzheimer s & Dementia Open access 18 Oct 2019 64
13 Comparative semantic profiles in semantic dementia and Alzheimer’s disease David J. Libon, Katya Rascovsky, John Powers et al. · Brain Open access 3 Jul 2013 57
14 The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier) Adam L. Boxer et al. · Alzheimer s & Dementia Open access 10 Oct 2012 56
15 The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology Michael G Benatar et al. · Nature Reviews Neurology ReviewOpen access 20 May 2024 52
16 Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint Adam M. Staffaroni et al. · Alzheimer s & Dementia Open access 11 May 2019 51
17 Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance Max‐Joseph Grimm et al. · Movement Disorders Open access 11 Sep 2020 46
18 Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration Nicholas T. Olney et al. · Alzheimer s & Dementia Open access 26 Nov 2019 46
19 Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort Hilary W. Heuer et al. · Alzheimer s & Dementia Open access 2020 45
20 Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration Adam M. Staffaroni et al. · Alzheimer s & Dementia Open access Jul 2019 40
21 Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research Sanne Franzen et al. · Alzheimer s & Dementia Open access 3 Jun 2023 37
22 Brain volumetric deficits in MAPT mutation carriers: a multisite study Stephanie A. Chu et al. · Annals of Clinical and Translational Neurology Open access 28 Nov 2020 36
23 Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit Rita Sattler et al. · Neurology and Therapy Open access 17 Oct 2023 34
24 A framework for translating tauopathy therapeutics: Drug discovery to clinical trials Howard Feldman et al. · Alzheimer s & Dementia Open access 24 Sep 2024 26
25 Nonlinear Z‐score modeling for improved detection of cognitive abnormality John Kornak et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access Dec 2019 26
26 ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium Lavanya Jain et al. · Alzheimer s & Dementia Open access 23 Sep 2023 22
27 Frontotemporal Dementia Caregivers and Researchers Mary Guerriero Austrom, Susan L.-J. Dickinson, Sharon S. Denny et al. · American Journal of Alzheimer s Disease & Other Dementias® Open access Sep 2011 22
28 Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers Qin Chen et al. · Neurobiology of Aging Open access 15 Aug 2019 20
29 Caring for Children of Parents With Frontotemporal Degeneration Sharon S. Denny, Darby Morhardt, J. Elise Gaul et al. · American Journal of Alzheimer s Disease & Other Dementias® Open access 3 Oct 2012 19
30 Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research Karen Nuytemans et al. · Alzheimer s & Dementia Open access 13 Nov 2024 17
31 Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact Megan S. Barker, Shana G. Dodge, Debra Niehoff et al. · Journal of Geriatric Psychiatry and Neurology Open access 9 Aug 2022 16
32 The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All Allyson C Rosen et al. · Journal of Alzheimer s Disease Open access 2 Aug 2022 16
33 Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort Melanie Tara Gentry et al. · Alzheimer s & Dementia Open access 13 Jul 2020 13
34 Putting participants and study partners FIRST when clinical trials end early Emily A. Largent, Sarah J. Walter, Nancy M. Childs et al. · Alzheimer s & Dementia Open access 2 Aug 2022 12
35 iCare4Me for FTD: A pilot randomized study to improve self‐care in caregivers of persons with frontotemporal degeneration Lauren M. Massimo, Karen B. Hirschman, Subhash Aryal et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access Apr 2023 8
36 Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium Gregory David Scott et al. · Preprints.org PreprintOpen access 7 Sep 2021 8
37 Developing digital health technologies for frontotemporal degeneration Naomi Nevler, Debra Niehoff, Amanda M. Gleixner et al. · Alzheimer s & Dementia Open access Apr 2025 6
38 Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassays Udit Sheth, Rebecca Harrison, Kyle L. Ferber et al. · Clinical Chemistry and Laboratory Medicine (CCLM) Open access 8 Sep 2025 5
39 The Importance of Offering Genetic Counseling and Testing to All Persons Diagnosed With Frontotemporal Degeneration Spectrum Disorders Laynie Dratch, Kim Jenny, Kristiana Salmon et al. · Neurology 18 Jul 2025 5
40 Design considerations for C9orf72 disease prevention trials Michael G Benatar et al. · Brain Open access 3 Aug 2025 4
41 Data stewardship in FTLD research: Investigator and research participant views Jalayne J. Arias, Ana M. Tyler, Laura M. Beskow et al. · Alzheimer s & Dementia Open access 8 Mar 2024 3
42 AFTD: Making Connections and Building Resources Susan L.-J. Dickinson, Sharon S. Denny · Journal of Molecular Neuroscience 10 Oct 2011 3
43 The formation of the advisory group on risk evaluation education for dementia Allyson C Rosen et al. · Alzheimer s & Dementia Open access Dec 2020 2
44 Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients With Frontotemporal Lobar Degeneration R.K. Magee, Sharon Xiangwen Xie, Daniel T. Ohm et al. · Neurology 21 Jul 2026 1
45 The Frontotemporal Degeneration (FTD) Clinical Research Learning Institute Shana G. Dodge, Meaghan Sharp, Wanda Smith et al. · Innovation in Aging Open access Dec 2025 1
46 Supporting frontline staff in frontotemporal degeneration research Shana G. Dodge, Danelle J. Carter, Dahlia Kamel et al. · Frontiers in Neurology Open access 11 Sep 2026 0
47 TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging Michael Benatar et al. · JAMA Neurology 24 Aug 2026 0
48 Disconnected: How Frontotemporal Degeneration Leads to Isolation Regardless of Residence (P6-13.012) Mary Krause, Carrie Milliard, Robert Reinecker et al. · Neurology 9 Jun 2026 0
49 Frontotemporal degeneration (FTD) diagnosis and impact Esther Kane, Shana G. Dodge, Carrie F Milliard et al. · Innovation in Aging Open access Dec 2025 0
50 Genetic testing rates of individuals diagnosed with FTD and close biological relatives assessed in the FTD Insights Survey Devon M. Chenette, Stella Mayo McCaughey, Robert Reinecker et al. · Alzheimer s & Dementia Open access Dec 2025 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.